Current Standards and Ongoing Controversies in the Management of Locally Advanced Non-Small Cell Lung Cancer

Trial schema for INT 0139.⁹

Progression-free survival, INT 0139.⁹

Overall survival, INT 0139.⁹

Trial schema for proposed Intergroup trial for resectable stage IIIA N2 NSCLC.

Trial schema for CALGB trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone.²³

Trial schema for SWOG protocol 0023, evaluating maintenance gefitinib after concurrent chemoradiotherapy and consolidation chemotherapy with docetaxel.

Hoosier Oncology Group trial schema evaluating the benefit of consolidation docetaxel after concurrent chemoradiotherapy.

Trial schema for Locally Advanced Multimodality Protocol (LAMP).²⁷